 SAN DIEGO, Oct. 01, 2021 GLOBE NEWSWIRE -- Cidara Therapeutics, Inc. Nasdaq: CDTX, a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious diseases, today announced that the Compensation Committee of its Board of Directors granted non-qualified stock option awards and restricted stock units for an aggregate of 169,000 shares of its common stock to ten new employees, pursuant to the Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan, with a grant date of September 30, 2021. Each of the stock options has an exercise price of 2.24 per share, which is equal to the closing price of Cidaras common stock on the grant date. The shares subject to the options will vest over four years, with 25 of the shares vesting on the one-year anniversary of the applicable vesting commencement date and the balance of the shares vesting in a series of 36 successive equal monthly installments thereafter. All RSUs vest in four equal annual installments, with 14 vesting on each of the first, second, third and fourth anniversaries of the Quarterly Vesting Date that occurs during the calendar quarter that includes the Date of Grant, subject to the participants Continuous Service through each such vesting date. Quarterly Vesting Date means March 10, June 10, September 10 or December 10.The awards are subject to the award holders continuous service through each vesting date and to the terms and conditions of the companys 2020 Inducement Incentive Plan and its standard forms of grant agreements thereunder. 